Ye Tian
Fortuna: 14 M $ al 31/07/2026
Fortuna: 14 M $ al 31/07/2026
Ye Edward Tian has been working at IMPACT Therapeutics, Inc. since 2014 and holds the position of Chief Scientific Officer, Executive Director & EVP starting in 2025.
The education history includes an undergraduate degree from Tsinghua University conferred in 1982, a graduate degree from the Chinese Academy of Sciences conferred in 1986, and a doctorate from Michigan State University conferred in 1992.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 10/06/2026 | 8.422.233 ( 2,98 % ) | 14 M $ | 31/07/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| IMPACT THERAPEUTICS, INC | Director Técnico/Científico/I+D | 01/06/2014 |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 4 |
|---|---|
Michigan State University
Michigan State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Tsinghua University
Tsinghua University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Chinese Academy of Sciences
Chinese Academy of Sciences Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
IMPACT Therapeutics, Inc.
IMPACT Therapeutics, Inc. BiotechnologyHealth Technology Operates as a commercial-stage biotechnology company that develops anti-cancer therapies and pharmaceutical products | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.